Trial intelligence / Profile preview

Enstilar in Psoriasis Vulgaris

NCT01536886Phase 2Completed

Sponsor
LEO Pharma
Start
May 2012
Primary completion
Sep 2012
Countries
1
01

Overview

A Phase 2 trial of calcipotriol in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started May 2012; status: completed.

02

Drugs

calcipotriol
03

Conditions

Psoriasis vulgaris (PV)

Beyond the preview

Go deeper on NCT01536886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01536886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call